The week in pharma: action, reaction and insight – week to December 16, 2022

19 December 2022
tpl-week-in-review-700x466

By Barbara Obstoj-Cardwell. Editor

Last week saw the announcements of the biggest pharmaceutical M&A and licensing deals of the year. US biotech giant Amgen, which will soon be facing competition from biosimilars, agreed to fork out around $28 billion to acquire Horizon Therapeutics. Another US biotech, Clovis Oncology, has finally thrown in the towel, filing for Chapter 11 bankruptcy, and a “stalking-horse” deal with Novartis. Japan’s largest drugmaker Takeda announced a licensing deal with Nimbus Therapeutics for the latter’s autoimmune candidate NDI-034858, re-coded TAK-279, paying a massive $4 billion upfront.

Horizon acquisition key considerations

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology